Pneumococcal vaccine safety and effectiveness study for 2-month-old infants
Part of Infections clinical trials.
This study tests a pneumococcal vaccine (PCV13) in healthy 2-month-old babies to see if it is safe and helps protect against pneumococcal infections. Your baby would receive the vaccine and be monitored for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between 42 and 89 days old (approximately 2 months)
- Your baby was born at 37 weeks of pregnancy or later (not premature)
- Your baby is generally healthy with no serious birth defects, genetic disorders, or chronic illnesses
- You can provide your baby's vaccination records from birth
- Your baby has not received any pneumococcal vaccines before
- Your baby's mother tested negative for HIV, syphilis, hepatitis B, and hepatitis C
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests giving babies two different types of polio vaccines in a specific order to see which is safer and more effective. If your baby is about 2 months old and hasn't had any polio vaccine yet, they may be able to join.
This study tests a new pneumococcal vaccine (PCV24) for babies ages 2 to 23 months. It aims to see if the vaccine is safe and helps protect against serious infections like pneumonia and meningitis.
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
This trial tests a new pneumococcal vaccine (PCV24) in healthy infants and children. It aims to protect against serious infections like pneumonia and meningitis caused by pneumococcal bacteria.
Hear when a new Pneumococcal Infectious Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.